Form D · Pharmaceuticals
Nimbus Discovery, LLC
Cambridge, MA · CIK 0001490403
Offering snapshot reported Mar 11, 2011 · SEC filing
- Reported sold
- $1.5M Offering amount: $15M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 28, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 11, 2011 | Initial | $1,500,000 | No comparison | 3 | SEC filing |
| Apr 29, 2010 | Initial | $3,500,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-156591
Source: Form D, filed Mar 11, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Bruce Booth | Director |
| Ramy Farid | Director |
| Vicki Sato | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
25 First Street Suite 303
Cambridge, MA, 02141
Cambridge, MA, 02141